Drug Type Small molecule drug |
Synonyms CF-1983 mesylate, CNF 2024, CNF-2024 + [1] |
Target |
Mechanism HSP90B inhibitors(Heat shock protein HSP 90-beta inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC15H19ClN6O4S |
InChIKeyQQYUAUPJJLOCHU-UHFFFAOYSA-N |
CAS Registry1225041-97-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hormone receptor positive breast cancer | Phase 2 | US | 01 Nov 2009 | |
Hormone receptor positive breast cancer | Phase 2 | AU | 01 Nov 2009 | |
Hormone receptor positive breast cancer | Phase 2 | BE | 01 Nov 2009 | |
Hormone receptor positive breast cancer | Phase 2 | RU | 01 Nov 2009 | |
Gastrointestinal Stromal Tumors | Phase 2 | US | 01 Feb 2008 | |
HER2 Positive Breast Cancer | Phase 1 | US | 01 Dec 2007 | |
HER2-negative breast cancer | Phase 1 | US | 01 Dec 2007 | |
Advanced Malignant Solid Neoplasm | Phase 1 | US | 01 Feb 2006 | |
Advanced Malignant Solid Neoplasm | Phase 1 | GB | 01 Feb 2006 | |
Chronic Lymphocytic Leukemia | Phase 1 | US | 01 Feb 2006 |
Phase 1 | 23 | ohkwhziarw(xarhdngdil) = nckyxnneqq mciwytworu (xvpfyopgnr ) | - | 20 May 2008 |